Document is current
Any future updates will be listed below
-
Authors
Mercado, Nicolas https://orcid.org/0000-0002-8728-0994
Schutzius, Gabi https://orcid.org/0000-0001-7867-6199
Kolter, Christian https://orcid.org/0000-0001-5174-6126
Estoppey, David https://orcid.org/0000-0002-6631-7487
Bergling, Sebastian https://orcid.org/0000-0002-6840-3266
Roma, Guglielmo https://orcid.org/0000-0002-8020-4219
Gubser Keller, Caroline
Nigsch, Florian https://orcid.org/0000-0002-2919-8749
Salathe, Adrian https://orcid.org/0000-0001-5715-7883
Terranova, Remi https://orcid.org/0000-0002-2119-679X
Reece-Hoyes, John
Alford, John
Russ, Carsten
Knehr, Judith
Hoepfner, Dominic https://orcid.org/0000-0001-8450-7543
Aebi, Alexandra https://orcid.org/0000-0001-8078-8739
Ruffner, Heinz
Beck, Tanner C.
Jagannathan, Sajjeev
Olson, Calla M.
Sheppard, Hadley E.
Elsarrag, Selma Z.
Bouwmeester, Tewis
Frederiksen, Mathias https://orcid.org/0000-0002-2076-3748
Lohmann, Felix
Lin, Charles Y. https://orcid.org/0000-0002-9155-090X
Kirkland, Susan https://orcid.org/0000-0003-1464-1063
- License Information
-
More Information
Article History
Received: 9 November 2018
Accepted: 14 September 2019
First Online: 14 October 2019
Competing interests
: Most authors (with the exception of C.Y.L., T.B., S.J., C.M.O., H.E.S., S.E., all Baylor, TX) were employees of Novartis during the course of this work, as indicated in the affiliations. C.Y.L. received sponsored travel from Novartis and is a shareholder and inventor of IP licensed to Syros Pharmaceuticals. Some authors own shares in Novartis. The remaining authors declare no competing interests.
